Comments

Arbutus Biopharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

ABUSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.53

-0.05-1.40%

At close: -

$3.60

0.071.98%

After Hours: 5:55 PM EDT

Arbutus Biopharma (ABUS) Forecast

News Earnings Arbutus Biopharma (ABUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Arbutus Biopharma Stock Price, Quotes and Forecasts | NASDAQ:ABUS | Benzinga

Explore Arbutus Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABUS.

Open	$3.53
Close	$3.53
Volume / Avg.	515.44K / 934.70K
Day Range	$3.49 - $3.60
52 Wk Range	2.71 - 4.72
Market Cap	$689.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	9.46%
Days to Cover	15.97

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.53
Close	$3.53
Volume / Avg.	515.44K / 934.70K
Day Range	$3.49 - $3.60
52 Wk Range	2.71 - 4.72
Market Cap	$689.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	9.46%
Days to Cover	15.97

About Arbutus Biopharma Corp

Sector

Healthcare

Industry

N/A

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases....

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arbutus Biopharma (ABUS) stock?

You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.

View our list of the best stock brokerages

Who are Arbutus Biopharma (ABUS) competitors?

There are no as such competitors for Arbutus Biopharma.

What is the forecast, or price target, for Arbutus Biopharma (ABUS) stock?

Arbutus Biopharma has a consensus price target of $5.50.

What is the current price for Arbutus Biopharma (ABUS)?

The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $3.6 last updated June 13, 2025 at 5:55 PM EDT.

Does Arbutus Biopharma (ABUS) pay a dividend?

There are no upcoming dividends for Arbutus Biopharma.

When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?

Arbutus Biopharma’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Arbutus Biopharma (ABUS) going to split?

There is no upcoming split for Arbutus Biopharma.

What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.